| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/18/2004 | CN1522149A Promoting whole body health |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1522142A Potassium channel opener |
| 08/18/2004 | CN1522132A Composition for freshening nostrils and sinus cavities |
| 08/18/2004 | CN1520868A Chinese herbal medicine compound preparation for treating asthma |
| 08/18/2004 | CN1520863A Formula and formulation of oral preparation for caring lung, maintaining appearance and invigorating the kidney using lily as main material |
| 08/18/2004 | CN1520861A Drug for upper respiratory tract infection |
| 08/18/2004 | CN1520820A Slow release levodropropizine pharmaceutical composition |
| 08/18/2004 | CN1520748A Pharynx-clearing and throat-moistening health food |
| 08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
| 08/18/2004 | CN1162181C Methods and composition for treatment of immunologically-mediated diseases using cow mycobacterium |
| 08/18/2004 | CN1162179C Medicament for curing rhinitis |
| 08/18/2004 | CN1162157C Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 08/17/2004 | US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate |
| 08/17/2004 | US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 08/17/2004 | US6777421 Treating a condition selected from the group consisting of anxiety, depression, substance abuse, neuropathic pain, acute pain, migraine, asthma, cough and improved cognition, in a subject in need thereof comprising administering a compound |
| 08/17/2004 | US6777418 For treating or preventing emphysema, cancer and dermatological disorders |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777403 Method and structure for inhibiting activity of serine elastases |
| 08/12/2004 | WO2004067526A1 CRYSTAL OF (23S)-1α-HYDROXY-27-NOR-25-METHYLENEVITAMIN D3-26,23-LACTONE AND PROCESS FOR PRODUCING THE SAME |
| 08/12/2004 | WO2004067525A1 Vitamin d3 lactone derivative |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004067026A1 Regulation of allergen induced gene |
| 08/12/2004 | WO2004067019A1 Antiallergic agent containing ground lotus or lotus extract |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004067006A1 Combination of a pde iv inhibitor and a tnf-alpha antagonist |
| 08/12/2004 | WO2004066960A2 Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004026311A3 Use of specific inhibitors of tyrosine kinases for immunomodulation |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004011611A3 Taci antibodies and uses thereof |
| 08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/12/2004 | WO2003057133A9 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040158076 Tyrosine derivatives |
| 08/12/2004 | US20040158071 Novel benzylpiperidine compound |
| 08/12/2004 | US20040157933 Cycloalkenone derivative |
| 08/12/2004 | US20040157930 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157858 Piperazine derivatives as tachykinin antagonists |
| 08/12/2004 | US20040157854 CCRS antagonists useful for treating aids |
| 08/12/2004 | US20040157853 Thiazolopytimidines and their use as modulators of chemokine receptor activity |
| 08/12/2004 | US20040157844 6-azauracil derivatives as thyroid receptor ligands |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157830 Formailide derivatives as beta2-adrenoreceptor agonists |
| 08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/12/2004 | US20040157822 Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 08/12/2004 | US20040157815 fluticasone propionate is completely dissolved in a hydrofluoroalkane (HFA) propellant for use in metered dose inhalers |
| 08/12/2004 | US20040157806 4-Dedimethylamino tetracycline compounds |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157772 Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156885 Water soluble film for oral administration with instant wettability |
| 08/12/2004 | US20040156859 GP-41 peptides, BBB peptides, anticancer agents, antihistamines, bronchodilators, hypotensive agents, antiangina agents, opioids, analgesics, antidepressants, and hypothyroid agents reactive with amino, hydroxyl or thiol groups |
| 08/12/2004 | US20040156847 Remedies for eosinophilic diseases |
| 08/12/2004 | US20040156827 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 08/12/2004 | DE10304294A1 N-Substituierte(Benzoimidazol-2-yl)-phenyl, Verfahren zu ihrer Herstellung , ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament N-substituted (benzoimidazol-2-yl) -phenyl, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/12/2004 | CA2514575A1 Crystal of (23s)-1.alpha.-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/12/2004 | CA2512808A1 Regulation of allergen induced gene |
| 08/12/2004 | CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/11/2004 | EP1445250A1 Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same |
| 08/11/2004 | EP1444981A1 Intracellular calcium concentration increase inhibitors |
| 08/11/2004 | EP1444349A2 Process for the preparation of ramipril |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444248A2 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 08/11/2004 | EP1444234A2 Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 08/11/2004 | EP1444233A2 A 2b? adenosine receptor antagonists |
| 08/11/2004 | EP1444232A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase |
| 08/11/2004 | EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 08/11/2004 | EP1444219A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1444200A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1443952A2 A method of reducing mortality and morbidity associated with critical illnesses |
| 08/11/2004 | EP1443946A2 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443915A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1219619B1 3-amino-2-phenylpiperidine derivatives as substance p antagonists |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520408A Piperazine compounds |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520402A Unsymmetrical cyclic diamine compound |
| 08/11/2004 | CN1520400A Cyclic diamine compounds bearing six-membered cyclic groups |
| 08/11/2004 | CN1520395A Cycloalkenone derivative |